Comparison of the immunogenicity and tolerability of influenza A virus vaccine H1N1 [2009 A/H1N1 MF59-adjuvanted influenza vaccine] and influenza virus vaccine [seasonal 2009-10 virosomal-adjuvanted influenza vaccine], administered simultaneously and 1 month apart, in control subjects and paediatric kidney transplant patients.
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2011
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine (Primary) ; MF 59
- Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype
- Focus Pharmacodynamics
- 17 Feb 2011 New trial record